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Abstract: This study aims to investigate the combined use of cog-
nitive behavioral therapy (CBT) and the Psychopharmacotherapy 
in depression treatment. A bibliographic review that was carried 
out, looking for original works, bibliographic reviews, meta-anal-
ysis, and specialized textbooks. The combination of both therapies 
has been the first choice as a depression treatment in both mild 
and moderate patients and hospitalized patients classified with se-
vere depression. The isolated use of antidepressants can lead to 
a discontinuation because of its side effects. The combine treat-
ment increased the adherence and decreased the discontinuation 
rate of the therapy. The CBT as a solo treatment or combined with 
medication displayed superior efficiency rate than Psychopharma-
cological treatment alone. This research data suggests that CBT is 
essential in treatments with patients with chronic depression and 
with childhood traumas. 
Keywords: Depression. Cognitive-behavioral. Psychopharmacother-
apy. Antidepressants.
1 Professora Titular de Farmacologia da Faculdade de Medicina da UFMT-Cuia-
bá. Doutora em Patologia Experimental pela USP-SP. Mestre em Psicobiologia 
pela UFRN-Natal. Especialista e Farmacologia de Produtos Naturais pela UFMA/
UNIFESP. Especialista em Neuropsicologia Pelo IPOG-Cuiabá. Especialista em 
Terapia Cognitivo Comportamental pelo CEFE/FAIP-Cuiabá. Especialista em 
Avaliação Psicológica pelo IPOG-Cuiabá. Graduada em Psicologia pela UFMT-
-Cuiabá. Graduada em Farmácia pela UFPA-Belém. Graduada em Biologia pela 
UFPA-Belém E-mail: vanzeler@terra.com.br ORCID: já respondeu e-mail, está 
aguardando gerar o link LATTES: http://lattes.cnpq.br/3288066283438364
artigo Recebido em 24/07/2020. Aprovado em 27/07/2020.
COMBINED COGNITIVE-BEHAVIORAL THERAPY (CBT) AND  
PSYCHOPHARMACOTHERAPY IN THE TREATMENT OF DEPRESSION
Revista Direitos, trabalho e política social, CUIABÁ, V. 6, n. 11, p. 70-91, Jul./dez. 2020 71
TERAPIA COMBINADA COGNITIVO-COMPORTAMENTAL (TCC) E 
PSICOFARMACOTERAPIA NO TRATAMENTO DA DEPRESSÃO
Resumo: Com objetivo investigar a terapia combinada, cognitivo-
-comportamental (TCC) e psicofarmacoterapia no tratamento da de-
pressão, realizou-se uma revisão bibliográfica, buscando trabalhos 
originais, revisões e metanálises, em periódicos indexadas e livros 
textos especializados. A combinação destas terapias tem sido a pri-
meira escolha no tratamento da depressão em pacientes ambulato-
riais, e em pacientes internados em estado grave de depressão. Já o 
uso isolado de antidepressivos está sujeito ao abandono da terapia 
em consequência dos efeitos colaterais. A combinação de tratamento 
aumentou a adesão e reduziu a taxa de abandono. A TCC como tra-
tamento único ou combinada com medicamentos, mostrou eficácia 
superior a psicofarmacoterapia, isoladamente. A TCC tem se mos-
trado essencial no tratamento de pacientes com depressão crônica e 
com histórico de traumas na infância. 
Palavras-chave: Depressão. Cognitivo-comportamental. Psicofar-
macoterapia. Antidepressivos.
Introduction
According to the revised text of the Diagnostic and Statisti-
cal Manual of Mental Disorders, 5th edition (DSM5), depression in-
cludes: Rupt Mood Regulation Disruptive Disorder, Major Depres-
sive Disorder (MDD), Persistent Depressive Disorder (dysthymia), 
Disorder Premenstrual Dysphoric, Disorder Depressive Induced by 
Substances/Drugs, Depressive Disorder Dueto Another Medical 
Condition, Other Specified Depressive Disorder and Unspecified 
Depressive Disorder. These disorders have in common the pres-
ence of a sad, empty or irritable mood, accompanied by somatic and 
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cognitive changes that significantly affect the individual’s ability to 
function (DSM5,2014).
Botti et al, (2010), pointed out several factors related to the 
appearance of mental disorders, among the mare: poverty, sex (gen-
der), age, conflicts, disasters, physical illnesses and the family and 
social environment. The authors also state that the Mundial World 
Health Organization has been warning since the 1990s, about the 
prominent place that depression has occupied among public health 
problems, being considered one of the main causes of disability in 
the world. 
The World Health Organization reported that depression is 
one of the most common psychiatric disorders, affecting 350 million 
people worldwide (WHO, 2012), of all ages and social classes, any 
culture, and education level (MARTINS&AGUIAR, 2006). It has 
a high prevalence in adolescence and old age, and has been getting 
worse in the current century (FERREIRA et al. 2016).
Duailibi and da Silva,  (2014) highlighted that the 2:1 rela-
tionship between women and men at MDD has been questioned and 
that a study presented at  the XXIII Annual  Meeting of the Society 
of Behavioral Medicine in the United States, demonstrated that men 
are less likely to report depressive symptoms if asked directly about 
depression, but if asked indirectly for example about well-being, 
they report a greater number of symptoms. 
Depression is a long-term disorder, with a high probability 
of recurrence over years, being responsible for suffering and loss of 
quality of life, both for patients and their families, causing a decrease 
in school performance or at work, and aggravation can lead to sui-
cide (GREVET and KNIJNIK, 2001).
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Daskalopoulou, (2016), evidenced depression as a risk factor 
for cardiovascular diseases. On the other hand, depression can arise 
as a result of disabilities and limitations associated with chronic dis-
eases (KATON et al, 2007).
The report of the World Health Organization (WHO) (WHO, 
2001), highlights severe depression as the main cause of disability 
in the world, being the fourth among the main causes of pathologies 
worldwide. The 2009 WHO report (WHO, 2009), indicates that, un-
til 2020, depressive disorder should occupy the second place among 
all disabling diseases, with cardiovascular diseases just ahead of it.
Currently cognitive-behavioral therapy (CBT) and the psy-
cho pharmacotherapy are very effective tools in the treatment of de-
pression. These therapeutic forms are effective when used alone or in 
combination, however studies are needed that examine specifically 
the comparative effectiveness of psychotherapies with pharmaco-
therapy (KNAPP,2009).
The treatment  of depression comprises managements of 
different orders, which have objectives: to improve the quality of 
life, reduce the need for hospitalization, minimize the risk of suicide 
and reduce the recurrences of depressive crises, that is, eliminate 
symptoms, recover the individual’s functional and social capacity, 
avoiding the recurrence of the disorder. For this it is necessary to 
empathize and adhere to the treatment, be it psychotherapeutic, med-
icated or combined. In this sense, the treatment of depression usually 
involves the use of psychotherapies and /or medications, associated 
or not (BECK et al, 1979).
In recent years, several studies have been conducted on the 
effectiveness of treatments for depression. Such research provided 
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empirical support for interventional procedures that contributed to 
the reduction or remission of depressive symptoms (SEGAL et al, 
2002). Among these practices are psychotherapies, pharmacothera-
peutic treatments and combined treatments. This review will focus 
on studies that evaluate the use of combined CBT therapy and psy-
chopharmacotherapy for depression, looking at the possible benefits 
that this practice offers to patients.
1 Development
1.1 Cognitive-behavioral model of depression
The term cognitive therapy (CT) and the generic term CBT 
are used as synonyms to describe psychotherapies based on the cog-
nitive model. The term CBT is also used for a group of techniques 
in which there is a combination of a cognitive approach and a set of 
behavioral procedures. CBT is used as a broader term that includes 
both standard CT and theoretical combinations of cognitive and be-
havioral strategies (BECK, 2005).
The cognitive-behavioral model was proposed by Aaron 
Beck in the early 1960s and 1960s. This researcher observed that 
humor and negative behaviors us were usually the result of distorted 
thoughts and beliefs and not unconscious forces according to Freud-
ian theory (BECK, 1963).
Thus, depression could be understood as a result of dysfunc-
tional cognitions and cognitive schemes. Depression patients believe 
and act as if things are worse than they really are. This form of rea-
soning generated an approach emphasizing the thought called “cog-
nitive therapy” (BECK,1963).
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The cognitive model of depression highlights that the cogni-
tive, motivational and vegetative symptoms of this disorder can be 
caused and maintained by distortions in the three level of cognition: 
automatic thoughts (ATs), intermediate beliefs and central or nuclear 
beliefs (schemas). ATs are part of the cognitive processing flow un-
derlying the individual’s conscious processing. They occur quickly 
through the assessment of the meaning of an episode in your life 
(NEUFELD and CAVENAGE, 2010).
Intermediate beliefs are rules, attitudes or assumptions that 
arise in the form of affirmations such as “if”, then “or” “should”, are 
rigid, inflexible and imperative. It is also called underlying or condi-
tional assumptions. They form a set of beliefs, generally coherent, that 
support the central beliefs with which they are related (NEUFELD 
and CAVENAGE, 2010). According to White (2003), each person has 
a set of conditional beliefs that have been learned and added through-
out life, with the purpose of giving meaning to the world.
Central or core beliefs, also called schemas, are acquired 
very early in development, and act as true “filters” where recent in-
formation and experiences are processed. These beliefs derive from 
identification with significant people and perception of the attitudes 
of others towards yourself, but they are shaped by personal experi-
ences. In this way, a child’s environment facilitates the appearance of 
particular types of schemes, as well as inhabiting them. The scheme 
of a well-adjusted person, allows realistic assessments, whereas the 
schemes of ill-adjusted individuals lead to distortions that generate 
psychological disorders (Beck,1976).
Beck et al (1997) also emphasize that the central beliefs rep-
resent the mechanisms that people develop to deal with everyday 
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situations, that is, the way individuals perceive themselves, others, 
the world, and the future.
In this sense, Beck, (1967) postulated the so-called cognitive 
triad in which the depressed individual is suffering from the neg-
ative view of himself, his environment and the future. Therefore, 
depressed individuals perceive themselves as inferior, inadequate, 
unwanted, incapable (“nothing that I do works”), perceive the en-
vironment in which they are inserted as hostile, as insurmountable 
obstacles (“people treat me bad”); the vision of the future becomes 
influenced by negative cognitions, as it considers having insufficient 
resources to modify the future (“there is no use doing anything, I 
will never get out of it”), and consequently develop hopelessness 
(KNAPP et al, 2004).
When thoughts are associated with suicidal ideation, hope-
lessness makes them even more intense, with death being under-
stood by many depressive patients as a relief from psychological 
suffering or as the only way out of the perception of an impossible to 
be supported situation (POWELL et al, 2008).
Another item of central interest in the study of depressive 
disorders is cognitive distortions, or systematic errors in perception 
and information processing. Individuals with depression have a ten-
dency to structure experiences in an absolute and inflexible way, 
resulting in errors in interpretation how much to performance and 
judgment of external situations (BECK, 1995).
According to Powell et al, (2008) the most common cogni-
tive distortions in depressed patients were observed by Beck et al 
(1979), as a typological system, and among them are: arbitrary infer-
ence (early conclusion and with little evidence), selective abstraction 
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(tendency to choose evidence of its poor performance), over gener-
alization (tendency to consider that an even or negative performance 
will occur at other times) and personalization (personal attribution 
usually of a negative character) among others.
The distortions stem from rules and assumptions, which are 
stable patterns acquired throughout the life of the individual with 
depression. These rules and beliefs are sensitive to activation from 
primary sources such as stress and often lead to in effective interper-
sonal strategies (RUPKE et al, 2006).
Cognitive therapy for depression is a form of treatment that 
helps patients to modify beliefs and behaviors in order to change 
their depressed mood. For this purpose, CBT uses the following 
therapeutic strategies: 1) focus on automatic thoughts and depress 
genic schemes; 2) focus on the person’s style to relate to others; and 
3) change in behaviors the end in get better coping with the problem 
situation (LEAHY, 2017).
This therapy encourages the patient’s active participation in 
the treatment, leading them to: a) identify their own distorted percep-
tions; b) recognize your negative thoughts and try to replace them 
with alternative thoughts that reflect reality more closely; c) find the 
evidence that supports negative and alternative thoughts; and d) gen-
erate more accurate and credible thoughts associated with certain 
situations in a process called cognitive restructuring (BECK, 1995).
1.2 Biological model of depression
Depression is currently seen as the combination of biological 
and psychological factors, in which the manifestations and inten-
sities vary according to genetic, environmental and social factors. 
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It is also known that the biological basis of depression is based on 
theories that consider neurotransmitters (NT) and brain receptors as 
determining elements in depression. Among NT are monoamines 
such as catecholamines (dopamine (DA) and noradrenaline (NE)) 
and indolamine (5-hydroxytryptamine or serotonin (5HT)) (MÖSS-
NER, 2007).
Driven by a possible involvement of the NT in depression, 
several hypotheses have arisen over the decades. The first hypoth-
esis, was calling Hypothesis Catecholaminergic which was based 
on a possible catecholamine deficiency. Then came the Serotonergic 
Hypothesis, which was based on the fact that selective serotonin re-
uptake inhibitors (SSRIs) had been used with some success in the 
treatment of depression (MÖSSNER, 2007).
The demonstration that the continued use of tricyclic antide-
pressants (TADs) increased the behavioral response to AD, and the 
fact that the mechanism of action of TADs and monoamine oxidase 
inhibitors (MAOIs), increase the concentration of monoamines in 
cerebral synaptic clefts, supported the Dopaminergic Hypothesis. 
This and other information have over the years strengthened the 
relevance of the monoaminergic hypothesis of Depression (MÖSS-
NER, 2007).
On the other hand, there is great difficulty in considering 
these hypotheses as definitive since, whatever the antidepressant 
medication used, promotes an immediate increase in monoamines 
in the synaptic clefts, but the clinical improvement does not come 
after a few weeks. And there is still evidence that some substanc-
es increase monoamine levels without improving depression 
(BAHLS, 1999).
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Recent advances in neuroimaging studies allow a great-
er sense of the areas directly affected in depressed brains, having 
reduction volume and hypometabolism in the frontal lobes, basal 
ganglia and other medial and temporal structures of the brain, es-
pecially the connections between the basal nuclei, frontal lobes and 
the limbic system. Suggesting that brain changes in depression are 
located in more than a different structure and regions of the brain 
(ROZENTHAL, 2004).
1.3 Antidepressant medications
Since the late 1950s, antidepressant therapy has been per-
formed in clinical practice, which has represented an advance in the 
treatment and understanding of possible mechanisms related to de-
pressive disorders (PAYKEL, 1992 and STAHL, 1997). Thus, de-
pression has become a problem that can be treated. Until the 1980s 
there were two classes of antidepressants, TDAs and MAOIs. These, 
although very effective, had side effects, potentially lethal in cases 
of overdose (KESSEL, 1995). Beyond of that only 70% From pa-
tients if benefit with the TDAs, others need another class of antide-
pressants or even electroconvulsive therapy (MORENO et al, 1993) 
and there is still a lack of explanation for how antidepressants work 
(MORENO et al, 1999; SOUZA et al, 2015).
Antidepressants, regardless of chemical structures, have in 
common the ability to immediately increase the availability of one or 
more NT in the synaptic cleft. This effect is essential for the pharma-
cological response, but it does not explain the delay for the initiation 
of the clinical response (from 2 to 4 weeks). The mismatch between 
treatment and clinical response may be related to adaptive processes, 
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such as a sub sensitization of recipients whose resolution correlates 
with the beginning of clinical improvement (STAHL, 1997; SOUZA 
et al, 2015). 
2 Method
A literature review was carried out, seeking out works orig-
inal, bibliographic reviews and meta-analyzes, indexed (in CAPES 
journals, Lilacs PubMed, Medline, SciELO) and specialized text 
books, in order to describe the relationship between the combined 
use of CBT and Psychopharmacotherapy.
The inclusion criterion was the article dealing with thera-
peutic processes in unipolar depression regardless of the degree or 
presence of comorbidity and treatment being unique (CBT or antide-
pressants) or CBT association with pharmacotherapy.
3 Results and discussion
According to De JONGHE et al, (2001) The psychotherapy 
combined with psychopharmacotherapy is the first choice for treat-
ing depression in outpatients. Since CT and CBT can be useful, not 
only for outpatients, but also for hospitalized patients with severe 
depression, even when used alone (ANTONUCCIO, 1995; POW-
ELL, et al, 2008).
Greenberg and Fisher, (1989) carried out an extensive review 
verifying several clinical trials that compared active and directive 
psychotherapies (such as cognitive and interpersonal therapies) to 
psychopharmacotherapy with antidepressants. The results showed 
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that outpatients undergoing psychotherapy evolved as well or some-
times better than those who received medications.
When CT compared to imipramine (TDA) in depression, it 
was concluded that CT had significantly better results. However, this 
study did not have a placebo group as a control (RUSH et al, 1977).
In the 1980s, there was a considerable increase in the num-
ber of studies, which allowed a meta-analysis to be carried out in-
cluding 28 studies, in which it was shown that CBT was superior to 
antidepressants in the treatment of depression (DOBSON, 1989). In 
the subsequent years, other studies came indicating that CBT was 
significantly effective in depression and that it guaranteed a longer 
duration of effect compared to psychopharmacotherapy.
In a multicenter research on depression at the National Insti-
tute of Mental Health (NIMH), CBT was compared with interper-
sonal therapy (IPT), pharmacotherapy with imipramine and a place-
bo group. CBT was as effective as IPT and imipramine in mild and 
moderate depressions, however, in more severe depressions, IPT and 
imipramine showed better outcome (ELKIN et al, 1989).
Further analysis of this study by DeRubeis et al, (1999) 
showed significant differences in efficacy in different centers. In 
Philadelphia, where therapists’ loyalty to the model was more con-
sistent, CBT, IPT and imipramine had similar results. 
McPherson et al, (2005), analyzed CBT interventions in 
patients with depression and resistant to drug treatment. Con-
trol group studies underwent intervention with CBT and showed 
a reduction in depression scores after. Studies without control 
groups, although all reported improvement, only three showed 
statistical significance.
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On the other hand, the evidence still does not answer a series 
of relevant questions from a clinical point of view, such as: defini-
tion of treatment according to the type and severity of depression, 
cost-effectiveness of approaches combined and specific approaches 
for individual patients. The studies clinical provide more compre-
hensive responses, related to the general effectiveness of interven-
tions, being understood more as a basis for the indication of certain 
therapies (KNAPP et al, 2004).
Harrington et al, (1998) performed a meta-analysis of the 
effectiveness of CBT in adolescents and children with depressive 
disorder, with ages ranging from 6 to 19 years. Despite the small 
number of studies found, the rate of improvement suggests that CBT 
is as effective as ATCs.
Dobson, (1989) carried out a review that involved eight stud-
ies with a total of 721 depressed patients where it was compared to 
CT with tricyclic antidepressants. The results showed that CT was 
superior to psychopharmacotherapy when the Beck depression in-
ventory (BDI score) was used, patients undergoing CT achieved an 
improvement of 70% above the average of patients treated with psy-
chopharmacotherapy.
Antonuccio et al, (1995), reviewing controlled clinical stud-
ies not restricted to CT, suggest that psychotherapeutic treatments, 
particularly CBT, are at least as efficient as drugs in the case of se-
vere depressive disorder.
Another clinical trial was carried out by Keller et al (2000), 
which involved 681 patients with non-psychotic MDD in which ne-
fazodone was compared to CBT in a combined and isolated study. 
16 to 20 sessions were performed in 12 weeks, with the group that 
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received combined treatment showing remission or satisfactory re-
sponse in 85% of the cases while the nefazodone group alone ob-
tained the rate of 55%.
The randomized clinical trial carried out by Nemeroff et 
al, (2003) included 681 patients, from a multicenter study, with 
the aim of comparing monotherapy (nefazodone or CBT) with the 
combination of interventions, in individuals aged 18 to 75 years 
diagnosed with chronic MDD. Among the sample participants, 
65% were victims of abuse during childhood or were subjected to 
stressful events of great importance, such as: sexual or physical 
abuse, loss of a parent before the age of 15, or parental neglect. 
The results made it clear that patients who suffered early childhood 
trauma responded better to psychotherapy compared to patients 
treated with antidepressants alone, and even combination therapy 
(nefazodone and CBT) was only weakly superior to psychothera-
peutic monotherapy.
Even when variables such as age, gender, race and severity 
of depression at the baseline are controlled, psychotherapy with or 
without the association of nefazodone remained superior to treat-
ment with only the ingestion of the drug. Individuals with chronic 
depression and child trauma showed 48.3% remission of symptoms 
with psychotherapy, compared with 32.9% treated with nefazodone, 
whereas combined treatment led to remission of symptoms in 53.9% 
of patients. The data suggest that psychotherapy is essential in the 
treatment of patients with chronic depression and with a history of 
childhood trauma (NEMEROFF et al, 2003).
De Oliveira, (1998) concluded that, although the drugs are 
effective in improving sleep-related symptoms, psychotherapy was 
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more effective in helping patients with depression and apathy. In ad-
dition, unlike psychotherapy, medications proved to be incapable of 
helping out patients to adjust socially, in relation to professional per-
formance and interpersonal relationships.
Systematic reviews and meta-analyzes have found controver-
sial results, although in clinical practice there is a common sense that 
combined approaches are always preferable. Some reviews do not find 
superiority in relation to isolated treatments (KNAPP et al, 2004).
Most of the reviews presented included studies compar-
ing psychotherapy with ATCs, drugs that have been used more 
and more strictly, due to the low tolerability on the part of many 
patients, which allows a high rate of interruption treatment, due 
to adverse effects and end up compromising the effectiveness of 
the medication. Wexler and Cicchetti, (1992) state that when the 
rate of treatment abandonment is taken into account in the anal-
ysis along with the rate of clinical improvement, psychopharma-
cotherapy mac becomes much lower than isolated psychotherapy 
or combined treatment. Other studies that included nefazodone a 
non-tricyclic antidepressant, the results indicated that psychother-
apy and combination therapy have greater therapeutic efficacy in 
depression greater.
Most recent findings, point what the combination in psycho-
therapy and psychopharmacotherapy have been more accepted by 
patients than exclusive pharmacotherapy, with a lower proportion of 
treatment abandonment (De Jonghe et al, 2001). On the other hand, 
the new antidepressants are more selective and have a profile of 
greater tolerability on the part of patients.
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Conclusions
Currently, depressive disorder has been identified as one 
of the biggest problems for health services worldwide, and sev-
eral studies have emphasized the therapeutic efficacy of CBT in 
depression, making this form of therapy, considered a major in-
strument. Valuable in the treatment of this disorder. The combi-
nation of psychotherapy and psychopharmacotherapy, has been 
the first choice for treating depression in outpatients and CBT has 
been useful even in isolation for patients hospitalized in a severe 
state of depression.
It was shown in this review that CBT, combined or not with 
antidepressants, causes a reduction in the symptoms of MDD and 
that psychotherapeutic interventions are important tools in the man-
agement of depression regardless of age, sex (gender), social class or 
degree of depression. Some studies have shown that CBT is superior 
as a single treatment or combined with antidepressants, in relation-
ship monotherapy pharmacological. Other studies have indicated 
that CBT is equivalent in effectiveness to TDAs in adolescents and 
children with mild and moderate depressive disorder.
Clinical trials have observed remission of depression in 85% 
of patients who received combined CBT treatment with antide-
pressants, against 55% of patients who received medication as the 
only form of therapy. Another controlled clinical study, showed that 
CBT and other psychotherapies, are at least as efficient as drugs in 
the case of severe depressive disorder. CBT was of great relevance 
for depressed patients who presented early trauma, they respond-
ed better to psychotherapy than to psychopharmacotherapy, and the 
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combined therapy with antidepressants showed slight superiority to 
monotherapy with CBT.
The study suggests that psychotherapy is essential in treating 
patients with chronic depression especially those with a history of 
childhood trauma.
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